Opportunities and Challenges in the Cannabis Industry
Once an illegal and somewhat niche product, legal cannabis is now a fast-growing global industry impacting everything from pharmaceuticals, to beauty products, to packaging, to local banking. Hemp, a variety of the cannabis plant, is even finding its way into clothing and construction products.
According to BDS and Arcview Market Research, it’s estimated that global consumer spending on cannabis will reach $32B by 2022. That’s 3 times the current spending level.
Medical marijuana is already legal across most of the US, and 10 states (plus Washington DC) have legalized marijuana for recreational use. As of October 2018, it is now fully legal in all of Canada as well. The 2018 Farm Bill legalized hemp in the US, opening the door to a wealth of market opportunities.
In this white paper, based on the webinar of the same name, David Traylor, Sr. Managing Director at Golden Eagle Partners, brings 15 years of biotech operational experience combined with 6 years of experience in the cannabis industry. David is uniquely qualified to advise on today’s fast-growing cannabis sector and provide the implications for a broad span of industries and its investors.
In the white paper, you’ll learn:
- How the cannabis sector got to where it is today
- Major events that have helped build the industry
- The differences between marijuana and hemp
- Current challenges to the MJ and hemp industries
- What potential involvement the FDA may have
- What the future holds for MJ and hemp
- Opportunities and risks for investors
- And much more
To request the white paper, please complete the request form.
Scroll down for speaker bio or click here to watch a brief interview with Mr. Traylor.